Adar Poonawalla hopes to launch another Covid vaccine 'COVOVAX' by June 2021

The Covishield vaccine developed by Serum Institute of India (SII) received Emergency Use Authorisation (EAU) after going through established safety and immunogenicity in a well-prescribed regulatory process

The vaccine is currently being used in the country. After that, the Serum Institute of India is likely to launch a new vaccine against the virus soon.

The chief of Serum Institute of India Adar Poonawalla on Saturday (January 30, 2021) announced that the company is looking forward to launch a second coronavirus vaccine, which if approved, could be India's third COVID-19 vaccine.

The SII has claimed that Novavax, a vaccine undergoing trials, has shown 'excellent efficacy results' against the novel coronavirus.

Taking to Twitter, Poonawalla said, "Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!"

Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!

— Adar Poonawalla (@adarpoonawalla) January 30, 2021